ESMO ESMO Congress (European Society for Medical Oncology), medical conference exhibit hall
9.0 Exceptional

ESMO 2026

ESMO Congress (European Society for Medical Oncology)
📅 October 16-20, 2026 📍 Berlin, Germany (rotates annually across European cities) Host: European Society for Medical Oncology

By Buzzbox Media · Last reviewed August 3, 2026

28,000+
Attendees
250+
Exhibitors
Cost not published
Booth cost
~35%
Purchasing Auth.

What is ESMO?

The largest oncology meeting in Europe and the second-largest globally after ASCO. 28,000+ oncologists from 130+ countries. Critical for any oncology drug or device company with European or global ambitions, late-breaking ESMO abstracts move markets.

What are the key facts about ESMO?

  • Host organization: European Society for Medical Oncology
  • Primary specialty: oncology
  • Scale: mega
  • Geography: International
  • International attendance: ~80%
  • See all Oncology conferences

Which device categories fit ESMO?

imaging equipmentdiagnosticsdigital healthcapital equipment

Which buyer stages does ESMO fit?

awarenessconsiderationKOL

What does ESMO charge for booth space?

Cost not published

European Society for Medical Oncology does not publish booth pricing for ESMO that we can link to, so we do not list a figure here. We would rather show nothing than an estimate you cannot check. Ask them directly on the ESMO exhibitor page ↗.

See the full cost guide →

Planning the ESMO booth itself? Read our guide to medical conference booth design for booth types, union labor rules, and the corner upgrade.

Who attends ESMO?

medical oncologistresearcherkolindustry medical affairs

Oncologists from 130+ countries. ~70% oncologists, ~15% researchers, ~15% industry/other. Late-breaking abstracts drive global press coverage similar to ASCO.

  • Purchasing authority: ~35% of attendees
  • Effective buyers: ~9,800
  • International attendance: ~80%

Where is ESMO held?

  • Venue: Berlin, Germany (rotates annually across European cities)
  • Management company: ESMO (in-house)
  • Product theater: Available

Visit the official ESMO site ↗

Who else exhibits at ESMO?

Approximately 250+ exhibitors typically attend ESMO. Your competitors are here.

Is ESMO worth exhibiting?

Why Exhibit

The largest oncology meeting in Europe and the second-largest globally after ASCO. 28,000+ oncologists from 130+ countries. Critical for any oncology drug or device company with European or global ambitions, late-breaking ESMO abstracts move markets.

Why Skip

US-only device companies without European regulatory pathway (CE-mark or similar) will find the audience hard to convert. Like ASCO, the show is science-first and rewards companies with peer-reviewed clinical data.

What should exhibitors know before ESMO?

Industry symposia and satellite sessions outperform booth traffic at ESMO. KOL dinner programs and pre-congress investigator meetings are common patterns. European booth aesthetics: minimal, science-forward, no aggressive sales messaging.

What is the Buzzbox Score for ESMO?

9.0 / 10 (Exceptional)

9.0 out of 10. One of the strongest exhibiting opportunities in our index. Carried by growth trajectory (9.4: mega-scale and stable and ~250 exhibitors). The lightest dimension is data transparency (7.6, ). The largest oncology meeting in Europe and the second-largest globally after ASCO.

How we score

Six weighted factors, each scored on a 0 to 100 rubric then normalized to a 7.0 to 10.0 band. Every show on this list cleared a relevance bar to be included, so 7.0 is the floor; the number tells you how far the leaders pull ahead. A factor we cannot source is left unscored rather than estimated, and the overall score above was set before any figure behind it was withdrawn.

Audience Quality
8.7

Strong (8.7): 35% purchasing authority (clinician-heavy), 112:1 attendee-to-exhibitor ratio, and mega-scale floor (28,000 attendees).

Cost Efficiency Not scored

Not scored on cost: this organizer publishes no booth price we can link to.

Data Transparency
7.6

Solid (7.6): exhibitor count disclosed, and attendee purchasing-authority data published.

Exhibitor Experience
9.0

Standout (9.0): society-run exhibits (in-house), non-union venue (simpler, cheaper move-in), and product theater / demo stage available.

Editorial Value
8.9

Strong (8.9): honest "who should skip" guidance, the flagship / largest show in its niche, and product-theater opportunity for thought leadership.

Growth Trajectory
9.4

Standout (9.4): mega-scale and stable, ~250 exhibitors, and 28,000 attendees.

When are the ESMO exhibitor deadlines?

Detailed deadlines not yet published for ESMO. Check the official site for the application window.

Frequently Asked Questions

How much does a booth cost at ESMO?

ESMO does not publish booth pricing we can link to, so we do not list a cost for this show. Rather than estimate one, we point you at the organizer's exhibitor page to request current rates directly.

How many people attend ESMO?

ESMO draws approximately 28,000 attendees. Oncologists from 130+ countries. ~70% oncologists, ~15% researchers, ~15% industry/other. Late-breaking abstracts drive global press coverage similar to ASCO.

When and where is ESMO 2026?

ESMO 2026 takes place October 16-20, 2026. The venue is Berlin, Germany (rotates annually across European cities). European Society for Medical Oncology hosts the meeting.

How many ESMO attendees have purchasing authority?

About 35% of ESMO attendees hold purchasing authority, which works out to roughly 9,800 effective buyers out of approximately 28,000 attendees. Effective buyers multiplies total attendance by the share of attendees who hold purchasing authority. Both inputs are estimates drawn from organizer reporting and our own exhibitor research, so read the figure as directional rather than exact.

Who exhibits at ESMO?

Approximately 250+ exhibitors typically attend ESMO. The device categories that fit this floor are imaging equipment, diagnostics, digital health, and capital equipment.

How does Buzzbox Media score ESMO?

ESMO carries a Buzzbox Score of 9.0 out of 10 (Exceptional), with one caveat on this record: cost efficiency is not scored, because European Society for Medical Oncology publishes no booth price we can link to, and the overall score was set before that figure was withdrawn. The factors still scored are audience quality, data transparency, exhibitor experience, editorial value, and growth trajectory. Each factor is scored on a 0 to 100 rubric then normalized to a 7.0 to 10.0 band, and every conference in our index cleared a relevance bar to be listed, so 7.0 is the floor. On this record the highest is growth trajectory at 9.4 and the lowest is data transparency at 7.6.

Which conferences are similar to ESMO?